Chief Financial Officer
Mr. Asadorian brings more than 30 years of finance, strategy, and corporate development experience to Talphera. Prior to joining Talphera in August 2017, he served as the Chief Financial Officer of Amyris, Inc., a publicly traded commercial-stage biotechnology company, from 2015 to 2017. Prior to Amyris, Mr. Asadorian served as the Chief Financial Officer of Unilabs, a private equity–owned medical diagnostics company, from 2009 to 2014.
Mr. Asadorian started his career at PricewaterhouseCoopers (PwC), where he was a partner in its Transaction Services (M&A advisory) group. While at PwC, he advised Barr Pharmaceuticals, a publicly traded specialty pharmaceutical company, on its acquisition of PLIVA, a publicly traded pharmaceutical company. After the acquisition, Mr. Asadorian joined Barr as Senior Vice President and Chief Financial Officer of its PLIVA business from 2007 to 2009. In that role, he oversaw a global finance team and was responsible for Barr’s ex-US financial operations until its acquisition by Teva Pharmaceuticals.
Mr. Asadorian holds a Bachelor of Science in Business Administration degree from Xavier University and a Master of Business Administration degree from the University of Manchester (UK).